FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220796082> ?p ?o ?g. }

• W4220796082 endingPage "47" @default.
• W4220796082 startingPage "37" @default.
• W4220796082 abstract "Introduction. Infection caused by cytomegalovirus (CMV) is a serious problem for patients with weakened immunity, including patients with hematopoietic depression. The cases of complications associated with cytomegalovirus require antiviral therapy. However, during the natural mutation process, especially with prolonged use of drugs in suboptimal doses, CMV strains resistant to the action of antiviral drugs (such as ganciclovir, valganciclovir) may occur. Hypothetically, the emergence of resistance in the virus may cause a more aggressive course of infection, the ineffectiveness of antiviral therapy and, as a result, an increase in the number of deaths. In this regard, timely detection of mutations that can potentially lead to the resistance of the virus to antiviral drugs during hematopoietic stem cell transplantation (HSCT), as well as during organ and tissue transplantation, may be important when making a therapeutic decision. We describe three clinical cases for which the dynamics of the appearance of a mutant strain of CMV by the UL97 gene, which correlates with the viral load and clinical picture, is analyzed.The aim of the study was to determine the timing of the occurrence of mutations in CMV phosphotransferase UL97 gene associated with resistance to antiviral drugs in patients with hemoblastoses after allogeneic hematopoietic stem cell (allo-HSCs) transplantation.Material and methods. The study included 48 samples of CMV DNA isolated from the peripheral blood of three allo-HSCs recipients with CMV infection who were treated in the clinics of the FSBI «National Medical Research Center for Hematology» of the Ministry of Health of Russia with oncohematological diseases during 2015–2017. Patients received conditional codes (PR, PD, and FS). Mutations associated with antiviral therapy (AVT) resistance were identified in all patients. Sanger sequencing was used for mutation detection. The obtained DNA sequences were analyzed using Nucleotide BLAST and Genome compiler software. Mutations were searched in MRA mutation resistance analyzer software. The nucleotide sequences were compared with the UL97 reference sequence of the Merlin CMV strain using this software environment.Results and discussion. For all patients in whom the virus strains containing C592G (PR), C607F (PD) and C603W (FS) mutations were detected, the timing of the mutation occurrence was determined at days 187, 124 and 1184, respectively. The emergence of mutations with a high resistance factor was shown to be accompanied by an increase in viral load (VL), the appearance of a clinical picture characteristic of CMV infection and a lack of an adequate response to therapy with ganciclovir and its derivatives.Conclusion. Using these results, it is proposed to develop the test system based on random polymerase chain reaction (rPCR) to detect mutations in the most frequently encountered codons: M460I/V, C592G, A591V, A594T/V, L595F/S, C603W. Given that the data on the prevalence of these mutations were obtained from foreign sources, it is advisable to conduct similar studies on the frequency of mutations in the UL97 gene among the population of the Russian Federation in order to improve the quality and accuracy of test systems." @default.
• W4220796082 created "2022-04-03" @default.
• W4220796082 creator A5005814925 @default.
• W4220796082 creator A5007008947 @default.
• W4220796082 creator A5012442194 @default.
• W4220796082 creator A5012755116 @default.
• W4220796082 creator A5046495435 @default.
• W4220796082 creator A5062654278 @default.
• W4220796082 creator A5073085410 @default.
• W4220796082 date "2022-03-15" @default.
• W4220796082 modified "2023-10-01" @default.
• W4220796082 title "Mutations in the <i>UL97</i> gene of cytomegalovirus (<i>Herpesvirales: Herpesviridae: Cytomegalovirus: Human betaherpesvirus</i> 5) associated with ganciclovir resistance in recipients of allogeneic hematopoietic stem cells" @default.
• W4220796082 cites W2033367963 @default.
• W4220796082 cites W2046171234 @default.
• W4220796082 cites W2060322409 @default.
• W4220796082 cites W2068392260 @default.
• W4220796082 cites W2085681409 @default.
• W4220796082 cites W2090634114 @default.
• W4220796082 cites W2120492602 @default.
• W4220796082 cites W2124758522 @default.
• W4220796082 cites W2142948191 @default.
• W4220796082 cites W2167211752 @default.
• W4220796082 cites W2329856097 @default.
• W4220796082 cites W2912481674 @default.
• W4220796082 cites W3015844019 @default.
• W4220796082 cites W3021917769 @default.
• W4220796082 cites W4240290202 @default.
• W4220796082 doi "https://doi.org/10.36233/0507-4088-90" @default.
• W4220796082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35293187" @default.
• W4220796082 hasPublicationYear "2022" @default.
• W4220796082 type Work @default.
• W4220796082 citedByCount "0" @default.
• W4220796082 crossrefType "journal-article" @default.
• W4220796082 hasAuthorship W4220796082A5005814925 @default.
• W4220796082 hasAuthorship W4220796082A5007008947 @default.
• W4220796082 hasAuthorship W4220796082A5012442194 @default.
• W4220796082 hasAuthorship W4220796082A5012755116 @default.
• W4220796082 hasAuthorship W4220796082A5046495435 @default.
• W4220796082 hasAuthorship W4220796082A5062654278 @default.
• W4220796082 hasAuthorship W4220796082A5073085410 @default.
• W4220796082 hasBestOaLocation W42207960821 @default.
• W4220796082 hasConcept C126322002 @default.
• W4220796082 hasConcept C159047783 @default.
• W4220796082 hasConcept C203014093 @default.
• W4220796082 hasConcept C2522874641 @default.
• W4220796082 hasConcept C2776317777 @default.
• W4220796082 hasConcept C2776409557 @default.
• W4220796082 hasConcept C2777408962 @default.
• W4220796082 hasConcept C2777732132 @default.
• W4220796082 hasConcept C2777965375 @default.
• W4220796082 hasConcept C2779820661 @default.
• W4220796082 hasConcept C2780252810 @default.
• W4220796082 hasConcept C2780727368 @default.
• W4220796082 hasConcept C2911091166 @default.
• W4220796082 hasConcept C71924100 @default.
• W4220796082 hasConcept C86803240 @default.
• W4220796082 hasConceptScore W4220796082C126322002 @default.
• W4220796082 hasConceptScore W4220796082C159047783 @default.
• W4220796082 hasConceptScore W4220796082C203014093 @default.
• W4220796082 hasConceptScore W4220796082C2522874641 @default.
• W4220796082 hasConceptScore W4220796082C2776317777 @default.
• W4220796082 hasConceptScore W4220796082C2776409557 @default.
• W4220796082 hasConceptScore W4220796082C2777408962 @default.
• W4220796082 hasConceptScore W4220796082C2777732132 @default.
• W4220796082 hasConceptScore W4220796082C2777965375 @default.
• W4220796082 hasConceptScore W4220796082C2779820661 @default.
• W4220796082 hasConceptScore W4220796082C2780252810 @default.
• W4220796082 hasConceptScore W4220796082C2780727368 @default.
• W4220796082 hasConceptScore W4220796082C2911091166 @default.
• W4220796082 hasConceptScore W4220796082C71924100 @default.
• W4220796082 hasConceptScore W4220796082C86803240 @default.
• W4220796082 hasIssue "1" @default.
• W4220796082 hasLocation W42207960821 @default.
• W4220796082 hasLocation W42207960822 @default.
• W4220796082 hasOpenAccess W4220796082 @default.
• W4220796082 hasPrimaryLocation W42207960821 @default.
• W4220796082 hasRelatedWork W1992736476 @default.
• W4220796082 hasRelatedWork W1993975573 @default.
• W4220796082 hasRelatedWork W2005748468 @default.
• W4220796082 hasRelatedWork W2021067097 @default.
• W4220796082 hasRelatedWork W2027173317 @default.
• W4220796082 hasRelatedWork W2050415448 @default.
• W4220796082 hasRelatedWork W2160376452 @default.
• W4220796082 hasRelatedWork W2796623078 @default.
• W4220796082 hasRelatedWork W2884649084 @default.
• W4220796082 hasRelatedWork W4212940674 @default.
• W4220796082 hasVolume "67" @default.
• W4220796082 isParatext "false" @default.
• W4220796082 isRetracted "false" @default.
• W4220796082 workType "article" @default.